SPMS Option?

June 2009
PN;Jun2009, Vol. 63 Issue 6, p19
Trade Publication
The article provides information on the diagnoses and treatments of secondary progressive multiple sclerosis (SPMS), a form of MS characterized by irreversible decline in neurological and physical function. It states that patients can be diagnosed with SPMS if there are changes in coordination of legs and arms, balance and reflexes. Moreover, dirucotide (MBP8298) is believed to induce and maintain immune-system tolerance.


Related Articles

  • REFLEXION Trial: Delayed Treatment of First MS Event Increases Time to CDMS. Summers, Jaye // MD Conference Express;May2015, Vol. 15 Issue 9, p14 

    Many who experience a first demyelinating clinical event will convert to clinically definite multiple sclerosis. Data from the REFLEX and REFLEXION trials suggest that patients who receive early treatment with interferon beta 1-a will convert to multiple sclerosis later than patients who took...

  • Thirty Years with MS. JAKLIN, TERI // Naturopathic Doctor News & Review;Jul2015, Vol. 11 Issue 7, p25 

    A personal narrative is presented which explores the author's experience of working with older people diagnosed with multiple sclerosis (MS) after he himself was diagnosed with MS and discusses various lessons learnt to deal with MS.

  • Multiple sclerosis proves to be unpredictable, puzzling illness.  // South County Journal;10/31/2012, Vol. 47 Issue 44, pB1 

    The article focuses on a chronic disease called multiple sclerosis (MS) which affects the brain, optic nerves and spinal cord and offers information on its symptoms, diagnosis and treatments.

  • and finally ….  // Update;Jan2007, Vol. 74 Issue 1, p98 

    The article provides updates in medicine research. A study was made to monkeys, that were analyzed performing repeated tasks, which revealed slight differences in neural activity each time. A study on the use of Botulinium toxin in writer's cramp has shown to be superior to placebo. Meanwhile,...

  • Copaxane for MS treatment.  // Australian Journal of Pharmacy;Sep2013, Vol. 94 Issue 1120, p28 

    The article reports on the PreCISe study which found that early treatment using Copaxone may delay the clinically definite multiple sclerosis (CDMS) diagnosis by more than two-and-a-half years and may reduce the risk of the development by 41%.

  • Raising hope: the future of multiple sclerosis. Tullman, Mark // South County Journal;3/21/2012, Vol. 47 Issue 12, pB2 

    The article discusses the progress made in the research on multiple sclerosis (MS) in 2011 including risk factors, diagnosis and treatment.

  • Effect of Pentoxifylline on Recurrence in Patients With Multiple Sclerosis: A Non-Randomized Double-Blinded Placebo Controlled Clinical Trial. Moghaddam, Akbar Hamzei; Seiffaddini, Rostam; Najafzadeh, Asma; Ghaffaripour, Hossien Ali; Arasteh, Payam; Movahhedi, Zeinab; Khanjani, Narges // Zahedan Journal of Research in Medical Sciences;Nov2015, Vol. 17 Issue 11, p1 

    Background: The role of the immune system in multiple sclerosis (MS) has been proved. Pentoxifylline has an inhibitory effect on phosphodiesterase and the cytokine products. In some studies therapeutic effects of pentoxifylline have been documented in MS patients. Objectives: The aim of our...

  • Evaluation of Cortical Lesions Could Improve Diagnosis of MS. Williams, Glenn S. // Neurology Reviews;Oct2016, Vol. 24 Issue 10, p38 

    The article discusses a study of how evaluation of cortical lesions could improve diagnosis of multiple sclerosis (MS), which was presented at the 32nd Congress of the European Committee for Treatment and Research in MS.

  • Use of immune globulin therapy for multiple sclerosis. Walling, Anne D. // American Family Physician;11/1/1997, Vol. 56 Issue 7, p1880 

    Presents a summary of the article `Randomised Placebo-Controlled Trial of Monthly Intravenous Immune Globulin Therapy in Relapsing-Remitting Multiple Sclerosis,' by F. Fazekas from the journal `Lancet' dated 1997. Management for multiple sclerosis; Result of the study on patients receiving...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics